Loading stock data…
iRhythm Holdings, Inc. (IRTC)
$120.74-2.33 (-1.89%)
Market OpenUpdated 12:08 PM EDT
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
iRhythm Holdings, Inc. in the Healthcare sector is trading at $120.74 with a market capitalization of $4.2B. Wall Street consensus targets $176.14 (14 analysts), implying a +45.9% move over the next 12 months. The stock is currently near its 52-week low of $100.85, remaining 10.2% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. Risk note: MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +45.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $224.17M↑ | $199.39M↓ | $208.89M↑ | $192.88M↑ | $186.69M |
| Gross Profit | $163.21M↑ | $141.35M↓ | $148.06M↑ | $137.12M↑ | $132.86M |
| Operating Income | $11.41M↑ | -$16.18M↓ | $4.26M↑ | -$8.43M↑ | -$16.23M |
| Net Income | -$381,000↑ | -$13.93M↓ | $5.58M↑ | -$5.21M↑ | -$14.22M |
Peer Comparison
JNJUNHPFE
Fundamentals
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.17B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.32
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-7.50%
Volume
Today's trading volume
166,901
Recent News
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
1 Russell 2000 Stock with Promising Prospects and 2 We Turn Down
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
iRhythm Holdings (IRTC) Faces An Audit Committee Shift As Its Undervalued Narrative Holds
iRhythm Holdings (IRTC) informed investors that Board member and Audit Committee chair Brian Yoor resigned for personal reasons on August 12, 2026. Existing director Karen McGinnis will step in to chair the Audit Committee. iRhythm Holdings’ share price has been volatile over 2026, with a 30 day share price return of 12.72% and a 7 day gain of 6.81%. However, the year to date share price return is down 29.75% and the 1 year total shareholder return is down 26.74%, even though the 5 year total...
3 Small-Cap Stocks for Long-Term Investors
Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few under-the-radar businesses will continue prospering by anchoring themselves in unique market segments.
2 Reasons to Like IRTC (and 1 Not So Much)
iRhythm’s stock price has taken a beating over the past six months, shedding 27.5% of its value and falling to $115.17 per share. This may have investors wondering how to approach the situation.